PMCTPharmaCountry
    Inicio

Actualizaciones regulatorias

Novedades regulatorias de FDA, EMA, TGA y organismos globales

#3573 ×

UPDATED
Actualizaciones regulatorias
10 sept 2026•1 min de lectura
FDA Approves Chartwell Molecular Lamotrigine Tablet ANDA077783
FDA has approved ANDA 077783 for oral lamotrigine tablets (25‑200 mg) submitted by Chartwell Molecular, with multiple labeling submissions cleared.